CLRB   $0.3146  -7.98% Market Closed

Cellectar Biosciences Inc
Total Cash 25.87M
totalCashPerShare 0.638
EBITDA -47.40M
Total Debt 530.86K
quickRatio 1.705
currentRatio 1.84
Total Revenue
debtToEquity 3.857
Revenue/Share
ROA -1.65998
ROE -7.96674
grossProfits
freeCashflow -20.48M
operatingCashflow -45.17M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 66.24M
forwardPE -0.7246644
floatShares 29.60M
sharesOutstanding 40.57M
sharesShort 1.96M
sharesShortPriorMonth 1.62M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.31%
Short Ratio help_outline 8.73%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 0.127
Price To Book help_outline 16.15
earningsQuarterlyGrowth
netIncomeToCommon -52.96M
trailingEps -2.43%
forwardEps -2.83%
enterpriseToEbitda -1.40
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 4Q 2022
institutionsCount 42
lastUpdated Nov. 6, 2024, 6:23 p.m.